Alnylam Pharmaceuticals Analyst Ratings
Live Stock News: Market Climbs, Crypto Falls, Big Tech is Here and Trump Starts Signing Orders
Reported Friday, FDA Approves Daiichi Sankyo And AstraZeneca's DATROWAY AS A New Treatment Option For HR Positive, HER2 Negative Breast Cancer In The U.S.
8 Health Care Stocks Whale Activity In Today's Session
LVMH Is Once Again the Largest Company in Europe by Market Cap
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Argenx Cut to Sell at Deutsche Bank on Valuation
AstraZeneca, Daiichi Sankyo Antibody-drug Conjugate Dato-DXd Gains FDA Nod
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
AstraZeneca Said to Have Changed Management of Its China Unit
'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Amgen Announced FDA Approval Of LUMAKRAS Combined With Vectibix For KRAS G12C-Mutated Metastatic Colorectal Cancer; Phase 3 CodeBreaK 300 Study Showed More Than Doubled Progression-Free Survival (5.6 Months) Compared To SOC (2 Months); Primary...
Wall Street Today: Thursday Earnings Looked a Lot More Mixed, and Philly is Booming
AbbVie Retains Humira Market Share Above 70%: Report
Live Stock News: Sideways Trading Market After Big TSMC, UNH Earnings, Philly Economy is Booming
"Seladelpar Approved To Treat Adult Patients In The UK With Liver Illness; As With Any Medicine, The MHRA Will Keep The Safety And Effectiveness Of Seladelpar Under Close Review" - UK Gov
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest